AIM2 and neoplasm: In addition, the results of immunohistochemistry showed that AIM2, as well as the cell proliferation marker Proliferating Cell Nuclear Antigen (PCNA) in tumor tissues were significantly downregulated by luteolin (Fig. 8h).